Trial Profile
Phase II study of S-588410 as maintenance monotherapy after adjuvant chemotherapy in patients with completely resected non-small- cell lung cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Asudemotide (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 01 Apr 2015 New trial record